Islam Saqib
Insider CIK 1575408 · SBTX Director · SWTX Chief Executive Officer, Director · PASG Director · ALXN SVP, Chief Strat & Port. Off.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 109,329 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 250,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 260,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 176,411 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 769,804 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 22,760 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 579,749 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 325,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 954,869 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 201,857 | — | $0 | 201,857 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 23,600 | $54.24 | $1.28M | 968,469 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 11,600 | $55.15 | $639.7K | 956,869 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 1,400 | $56.13 | $78.6K | 955,469 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 600 | $56.89 | $34.1K | 954,869 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-03-03 | 2025-03-05 | 11,800 | $52.97 | $625.0K | 992,069 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-02-27 | 2025-03-05 | 30,756 | $53.41 | $1.64M | 1,003,869 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-20 | 2025-02-24 | 24,260 | $60.10 | $1.46M | 1,039,693 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-20 | 2025-02-24 | 5,068 | $61.24 | $310.4K | 1,034,625 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-14 | 2025-02-19 | 10,672 | $59.92 | $639.5K | 1,063,953 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-02-12 | 2025-02-14 | 13,186 | $59.28 | $781.7K | 1,074,625 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-02-12 | 2025-02-14 | 85,309 | — | $0 | 1,087,811 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-10 | 2025-02-12 | 48,000 | $53.30 | $2.56M | 1,002,502 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2025-01-10 | 2025-01-14 | 109,329 | — | $0 | 109,329 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-01-10 | 2025-01-14 | 74,834 | — | $0 | 1,050,502 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-06 | 2025-01-07 | 12,359 | $38.86 | $480.3K | 975,668 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-05 | 2025-01-07 | 12,872 | $38.19 | $491.6K | 988,027 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-04 | 2025-01-07 | 13,469 | $38.19 | $514.4K | 1,000,899 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-12-02 | 2024-12-04 | 3,989 | $41.85 | $166.9K | 1,014,368 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-12-02 | 2024-12-04 | 45,011 | $41.33 | $1.86M | 1,018,357 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 6,692 | $42.07 | $281.5K | 1,063,368 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 9,908 | $41.10 | $407.2K | 1,070,060 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-09-03 | 2024-09-04 | 32,400 | $40.10 | $1.30M | 1,079,968 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 33,240 | $39.40 | $1.31M | 1,128,128 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 8,760 | $40.57 | $355.4K | 1,119,368 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 400 | $42.09 | $16.8K | 1,112,368 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-06-03 | 2024-06-05 | 6,600 | $41.40 | $273.2K | 1,112,768 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 47,693 | — | $0 | 47,693 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-08 | 2024-01-08 | 17,904 | $41.53 | $743.6K | 256,264 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-05 | 2024-01-08 | 12,885 | $37.96 | $489.1K | 274,168 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-01-04 | 2024-01-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-01-04 | 2024-01-08 | 88,000 | — | $0 | 287,053 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-11-30 | 2023-12-01 | 199,053 | — | $0 | 199,053 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-06-27 | 2023-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2023-05-25 | 2023-05-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-01-07 | 2023-01-10 | 4,097 | $26.41 | $108.2K | 905,104 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-01-06 | 2023-01-09 | 8,400 | $27.52 | $231.2K | 909,201 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-01-05 | 2023-01-09 | 260,000 | — | $0 | 260,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-01-05 | 2023-01-09 | 84,175 | — | $0 | 917,601 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-06-10 | 2022-06-13 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 24,000 | — | $0 | 24,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-01-07 | 2022-01-11 | 5,893 | $56.06 | $330.4K | 851,695 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-01-07 | 2022-01-14 | 3,996 | $56.06 | $224.0K | 853,592 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-01-06 | 2022-01-10 | 244,258 | — | $0 | 244,258 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-01-06 | 2022-01-10 | 78,370 | — | $0 | 857,588 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-10-20 | 2021-10-20 | 10,083 | $58.67 | $591.6K | 779,218 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-10-19 | 2021-10-19 | 14,077 | $58.81 | $827.9K | 769,135 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-10-18 | 2021-10-19 | 38,340 | $58.59 | $2.25M | 783,212 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-07-20 | 2021-07-20 | 18,572 | $77.68 | $1.44M | 821,552 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-07-19 | 2021-07-20 | 43,928 | $76.09 | $3.34M | 840,124 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2021-06-04 | 2021-09-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-05-27 | 2021-05-28 | 16,918 | — | $0 | 16,918 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-20 | 2021-04-20 | 24,075 | $66.39 | $1.60M | 884,052 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-19 | 2021-04-20 | 38,425 | $69.04 | $2.65M | 908,127 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-01-20 | 2021-01-21 | 2,199 | $78.75 | $173.2K | 1,222,997 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-01-19 | 2021-01-21 | 60,301 | $78.54 | $4.74M | 1,225,196 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-01-07 | 2021-01-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-01-07 | 2021-01-11 | 37,500 | — | $0 | 1,285,497 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2020-12-03 | 2020-12-07 | 69,753 | — | $0 | 69,753 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 5,000 | $18.00 | $90.0K | 5,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-03-02 | 2020-03-04 | 325,000 | — | $0 | 325,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 16,918 | — | $0 | 16,918 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 905 | $138.91 | $125.7K | 43,799 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 44 | $139.77 | $6.1K | 46,134 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 1,430 | $138.02 | $197.4K | 44,704 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $144.34 | $57.7K | 47,312 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 300 | $143.61 | $43.1K | 47,012 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $142.12 | $56.8K | 46,612 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $145.49 | $58.2K | 47,712 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 36 | $146.38 | $5.3K | 48,112 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 434 | $141.77 | $61.5K | 46,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-04 | 2016-02-08 | 11,763 | — | $0 | 48,148 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-12-08 | 2015-12-08 | 950 | $190.00 | $180.5K | 36,385 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-11-02 | 2015-11-04 | 975 | $180.00 | $175.5K | 37,335 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-10-26 | 2015-10-29 | 1,558 | $168.44 | $262.4K | 38,310 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-04-27 | 2015-04-30 | 6,032 | $181.57 | $1.10M | 39,868 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-03-02 | 2015-03-03 | 228 | $180.34 | $41.1K | 39,432 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 5,100 | — | $0 | 39,660 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,500 | $171.15 | $256.7K | 34,560 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-05 | 2015-02-09 | 8,760 | — | $0 | 36,060 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-03 | 2014-11-04 | 28,125 | $89.23 | $2.51M | 46,875 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 935 | $190.52 | $178.1K | 27,300 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-03 | 2014-11-04 | 28,125 | $89.23 | $2.51M | 55,425 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 27,190 | $190.50 | $5.18M | 28,235 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 36,900 | $176.80 | $6.52M | 36,900 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 2,300 | — | $0 | 27,300 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-04-24 | 2013-04-26 | 75,000 | $89.23 | $6.69M | 75,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-04-24 | 2013-04-26 | 25,000 | — | $0 | 25,000 | SEC↗ |